Kolkata, West Bengal India (PressExposure) June 17, 2011 -- CordLife India has emerged as a new hope for parents of children suffering with life threatening diseases. For the first time in India mixed stem cell transplantation saved the life of five year old Moinam from Siliguri. Since birth Moinam was suffering from Ebeta Thalassemia, it was detected by doctors when he was five months old and then with no option Moinam had to go through regular andpainful process of blood transfusionuntil he was operated by the doctors of CordLife India by stem cell therapy.
Dr. Ashish Mukherjee conducted the transplant on 3rd April 2011 at the Netaji Subhash Chandra Bose Cancer research Institute in Kolkata. CordLife, Asia's largest stem cell bank had preserved the cord blood of Moinam's sister, Ahomaat the time of her birth and provided it to Moinam at the time of the transplant therapy. Dr.Mukherjee used Ahoma'scord blood cells for stem cell transplant. Ashim Pal Moinam's father said"consultation with several doctors confirmed that our son had Ebeta Thalassemia. Our search for right treatment began from then till we came across Dr Mukherjee who suggested and guided us on the procedure of stem cell therapy. Stem cell banking of our second child was the only way left to cure Thalassemia of our son. As suggested by doctors we planned for a second child and preserved our daughter's cord blood with CordLife".
Thalassemia is a blood disorder passed down through families (inherited) in which the body makes an abnormal form of hemoglobin, a protein in red blood cells that carries oxygen. The disorder results in excessive destruction of red blood cells or severe anemia, which leads to improper growth and many other complications in the body. Children suffering with Thalassemia are not able to live more than 10 years if they do not get proper treatment. In stem cell transplants two factors -HLA compatibility and the stem cell count, decides the success of treatment. "While cord bloodstem cells used alone often don't give us adequate count, bone marrow stem cells, on the other hand, could lead to Graft Versus Host Disease, triggered by the body's defense mechanism while the transfusion is being done. Used together the two therapies complement each other, it is the treatment of choice in such cases," explained Dr Mukherjee. A mixed stem cell transplant was done for Moinam; stem cells were taken from the cord blood and bone marrow of Moinam's sister.
"Transplants like these confirm CordLife's technology and our assurance to parents who bank with us their baby's cord blood. HLA matching was undertaken which provided that the tissues of both the children matched and the treatment could proceed. This is the first case of mixed stem cell transplant in India," Prosanto Chowdhury, Medical Director, Cord Life India, said.
By successfully doing India's first mixed stem cell transplant CordLife India has given a new hope of life to many children like Moinam.